Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Ophthalmology Market Research

Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Best Price Guarantee Length Publisher Published Date SKU
from $2,500 48 Pages GlobalData November, 2023 GBDT18367190
Best Price Guarantee
Price from $2,500
Length 48 Pages
Publisher GlobalData
Published Date November, 2023
SKU GBDT18367190

Ophthalmic Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies


Summary

GlobalData's Medical Devices sector report, “Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ophthalmic Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Ophthalmic Imaging Equipment Overview
4 Products under Development
4.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
4.2 Ophthalmic Imaging Equipment - Pipeline Products by Territory
4.3 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
4.4 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
5 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies
5.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
5.2 Ophthalmic Imaging Equipment – Companies Pipeline Products by Stage of Development
6 Ophthalmic Imaging Equipment Companies and Product Overview
6.1 Advanced Medical Electronics Corp Company Overview
6.1.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
6.2 Ai-Ris LLC Company Overview
6.2.1 Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview
6.3 Columbia University Company Overview
6.3.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
6.4 IDCP Scotland Ltd Company Overview
6.4.1 IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 JuneBrain, LLC Company Overview
6.5.1 JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.6 L.V. Prasad Eye Institute Company Overview
6.6.1 L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview
6.7 Leica Microsystems GmbH Company Overview
6.7.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.8 Physical Sciences Inc Company Overview
6.8.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.9 Singapore Eye Research Institute Company Overview
6.9.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
6.1 Spring Vision Ltd Company Overview
6.10.1 Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.11 TeleMedC Pte Ltd Company Overview
6.11.1 TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.12 University of South Florida Company Overview
6.12.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
7 Ophthalmic Imaging Equipment- Recent Developments
7.1 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer
7.2 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth
7.3 Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed
7.4 May 18, 2023: Gland Pharma announces statement of audited consolidated financial results for the quarter and year ended March 31, 2023
7.5 May 10, 2023: Optomed Announces Decisions of the Annual General Meeting and Board of Directors
7.6 May 10, 2023: LENSAR to report Q1 2023 financial results on Monday, May 15, 2023
7.7 Apr 03, 2023: Optomed Notice Of The Annual General Meeting
7.8 Mar 09, 2023: Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022
7.9 Mar 09, 2023: LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
7.1 Mar 02, 2023: Optomed Announces Annual Report 2022
7.11 Feb 16, 2023: Eyenuk Welcomes Paul Praino as Chief Commercial Officer
7.12 Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
7.13 Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
7.14 Jan 23, 2023: Gland Pharma’s Q3FY23 Revenue stood at ,383 Mn with Gross margin of 54%
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
Table 2: Ophthalmic Imaging Equipment - Pipeline Products by Territory
Table 3: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
Table 4: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
Table 5: Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
Table 6: Ophthalmic Imaging Equipment – Companies Pipeline Products by Stage of Development
Table 7: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Visual Imaging System - Product Status
Table 9: Visual Imaging System - Product Description
Table 10: Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Portable Retinal Imaging System - Product Status
Table 12: Portable Retinal Imaging System - Product Description
Table 13: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Smartphone Retinal Imaging Camera - Product Status
Table 15: Smartphone Retinal Imaging Camera - Product Description
Table 16: IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 17: D Eye Scanner - Product Status
Table 18: D Eye Scanner - Product Description
Table 19: JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Neuro-i SS-OCT - Product Status
Table 21: Neuro-i SS-OCT - Product Description
Table 22: L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Pediatric Perimeter - Product Status
Table 24: Pediatric Perimeter - Product Description
Table 25: Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Forveo - Product Status
Table 27: Forveo - Product Description
Table 28: Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Ophthalmic Imaging Instrument - Product Status
Table 30: Ophthalmic Imaging Instrument - Product Description
Table 31: Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Non-Invasive Imaging Tool - Product Status
Table 33: Non-Invasive Imaging Tool - Product Description
Table 34: Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: iCapture 45 - Product Status
Table 36: iCapture 45 - Product Description
Table 37: Next-Generation iCapture 45 - Product Status
Table 38: Next-Generation iCapture 45 - Product Description
Table 39: TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 40: EyeScan R2 - Product Status
Table 41: EyeScan R2 - Product Description
Table 42: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Ophthalmic Imaging System - Product Status
Table 44: Ophthalmic Imaging System - Product Description
Table 45: Glossary
2.2 List of Figures
Figure 1: Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
Figure 2: Ophthalmic Imaging Equipment - Pipeline Products by Territory
Figure 3: Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
Figure 4: Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date

$2,500
$5,000
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings